| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Rheumatology, Hospital for Joint Diseases and Division of Rheumatology, New York University School of Medicine, New York, NY 10003; and
Department of Veterans Affairs Medical Center and Departments of Medicine and Biochemistry, University of Tennessee, Memphis, TN 38163
It is recognized that there is molecular cross-talk between the inflammatory mediators NO and PGs that may regulate tissue homeostasis and contribute to pathophysiological processes. However, the literature is divided with respect to whether NO activates or inhibits PG production. In this study, we sought to determine whether conflicting observations could be accounted for by divergent effects of NO on the two cyclooxygenase (COX) isoforms. Exposure of resting macrophages to NO (30 µM) enhanced PGE2 release by 4.5-fold. This enhancement was inhibited by indomethacin but not by the COX-2 selective inhibitor NS398. To separate the activation of phospholipase A2 and COX, we performed experiments using fibroblasts derived from COX-1-deficient or COX-2-deficient mice. These cells exhibit increased basal PG production, which is due to a constitutively stimulated cytosolic phospholipase A2 and enhanced basal expression of the remaining COX isozyme. The exposure of COX- 2-deficient cells to exogenous NO (10 µM) resulted in a 2.4-fold increase of PGE2 release above controls. Further studies indicated that NO stimulated PGE2 release in COX-2-deficient cells, without altering COX-1 mRNA or protein expression. In contrast, NO inhibited COX-2-derived PGE2 production in both LPS-stimulated macrophages and COX-1 knockout cells. This inhibition was associated with both decreased expression and nitration of COX-2. Thus, these studies demonstrate divergent effects of NO on the COX isoforms. The regulation of PGE production by NO is therefore complex and will depend on the local environment in which these pleiotropic mediators are produced.
This article has been cited by other articles:
|
|
 |
|
  V. Rudolph and B. A. Freeman Cardiovascular Consequences When Nitric Oxide and Lipid Signaling Converge Circ. Res., September 11, 2009; 105(6): 511 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. K. Petropoulos, J.-A. C. Pournaras, A. N. Stangos, and C. J. Pournaras Effect of Systemic Nitric Oxide Synthase Inhibition on Optic Disc Oxygen Partial Pressure in Normoxia and in Hypercapnia Invest. Ophthalmol. Vis. Sci., January 1, 2009; 50(1): 378 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S C Mastbergen, J W J Bijlsma, and F P J G Lafeber Synthesis and release of human cartilage matrix proteoglycans are differently regulated by nitric oxide and prostaglandin-E2 Ann Rheum Dis, January 1, 2008; 67(1): 52 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Feleder, V. Perlik, and C. M. Blatteis Preoptic nitric oxide attenuates endotoxic fever in guinea pigs by inhibiting the POA release of norepinephrine Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1144 - R1151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Aisemberg, C. Vercelli, S. Billi, M. L. Ribeiro, D. Ogando, R. Meiss, S. M. McCann, V. Rettori, and A. M. Franchi Nitric oxide mediates prostaglandins' deleterious effect on lipopolysaccharide-triggered murine fetal resorption PNAS, May 1, 2007; 104(18): 7534 - 7539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sato, K. Ozaki, I. Oh, A. Meguro, K. Hatanaka, T. Nagai, K. Muroi, and K. Ozawa Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells Blood, January 1, 2007; 109(1): 228 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.R. Barnett, C. Schilling, C.R. Greenfeld, D. Tomic, and J.A. Flaws Ovarian follicle development and transgenic mouse models Hum. Reprod. Update, September 1, 2006; 12(5): 537 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. R. McCord, J.-L. Cracowski, and C. T. Minson Prostanoids contribute to cutaneous active vasodilation in humans Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2006; 291(3): R596 - R602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Sun, H. Liu, C. Yan, A. Jacobson, C. Ojaimi, A. Huang, and G. Kaley COX-2 contributes to the maintenance of flow-induced dilation in arterioles of eNOS-knockout mice Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1429 - H1435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Jerkic, J. V. Rivas-Elena, J. F. Santibanez, M. Prieto, A. Rodriguez-Barbero, F. Perez-Barriocanal, M. Pericacho, M. Arevalo, C. P.H. Vary, M. Letarte, et al. Endoglin Regulates Cyclooxygenase-2 Expression and Activity Circ. Res., August 4, 2006; 99(3): 248 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Lotz and J. A. Ulrich Innervation, Inflammation, and Hypermobility May Characterize Pathologic Disc Degeneration: Review of Animal Model Data J. Bone Joint Surg. Am., April 1, 2006; 88(suppl_2): 76 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. N. Jabbour, R. W. Kelly, H. M. Fraser, and H. O. D. Critchley Endocrine Regulation of Menstruation Endocr. Rev., February 1, 2006; 27(1): 17 - 46. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. N. Bratz and N. L. Kanagy Nitric oxide synthase-inhibition hypertension is associated with altered endothelial cyclooxygenase function Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2394 - H2401. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Simmons, R. M. Botting, and T. Hla Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition Pharmacol. Rev., September 1, 2004; 56(3): 387 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Gookin, L. L. Duckett, M. U. Armstrong, S. H. Stauffer, C. P. Finnegan, M. P. Murtaugh, and R. A. Argenzio Nitric oxide synthase stimulates prostaglandin synthesis and barrier function in C. parvum-infected porcine ileum Am J Physiol Gastrointest Liver Physiol, September 1, 2004; 287(3): G571 - G581. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-S. Chun, H.-H. Cha, J.-W. Shin, H.-K. Na, K.-K. Park, W.-Y. Chung, and Y.-J. Surh Nitric oxide induces expression of cyclooxygenase-2 in mouse skin through activation of NF-{kappa}B Carcinogenesis, March 1, 2004; 25(3): 445 - 454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Huang, D. Sun, Z. Wu, C. Yan, M. A. Carroll, H. Jiang, J. R. Falck, and G. Kaley Estrogen Elicits Cytochrome P450--Mediated Flow-Induced Dilation of Arterioles in NO Deficiency: Role of PI3K-Akt Phosphorylation in Genomic Regulation Circ. Res., February 6, 2004; 94(2): 245 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Harada, K. Okajima, M. Uchiba, and T. Katsuragi Contribution of capsaicin-sensitive sensory neurons to stress-induced increases in gastric tissue levels of prostaglandins in rats Am J Physiol Gastrointest Liver Physiol, December 1, 2003; 285(6): G1214 - G1224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Belik, R. P. Jankov, J. Pan, M. Yi, C. R. Pace-Asciak, and A. K. Tanswell Effect of 8-isoprostaglandin F2{alpha} on the newborn rat pulmonary arterial muscle and endothelium J Appl Physiol, November 1, 2003; 95(5): 1979 - 1985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Zauli, A. Pandolfi, A. Gonelli, R. Di Pietro, S. Guarnieri, G. Ciabattoni, R. Rana, M. Vitale, and P. Secchiero Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Sequentially Upregulates Nitric Oxide and Prostanoid Production in Primary Human Endothelial Cells Circ. Res., April 18, 2003; 92(7): 732 - 740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Liu, S.T.F. Chan, and R. Mahendran Nitric oxide induces cyclooxygenase expression and inhibits cell growth in colon cancer cell lines Carcinogenesis, April 1, 2003; 24(4): 637 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Chen, H. He, E. F. Mondejar, and G. Hedenstierna Cyclooxygenase inhibitor blocks rebound response after NO inhalation in an endotoxin model Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H290 - H298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-Q. Zhou, Y.-Q. Chen, J. H. Fisher, and M.-H. Wang Activation of the RON Receptor Tyrosine Kinase by Macrophage-stimulating Protein Inhibits Inducible Cyclooxygenase-2 Expression in Murine Macrophages J. Biol. Chem., October 4, 2002; 277(41): 38104 - 38110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bolli, K. Shinmura, X.-L. Tang, E. Kodani, Y.-T. Xuan, Y. Guo, and B. Dawn Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning Cardiovasc Res, August 15, 2002; 55(3): 506 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. H. Beierwaltes Cyclooxygenase-2 products compensate for inhibition of nitric oxide regulation of renal perfusion Am J Physiol Renal Physiol, July 1, 2002; 283(1): F68 - F72. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Shinmura, Y.-T. Xuan, X.-L. Tang, E. Kodani, H. Han, Y. Zhu, and R. Bolli Inducible Nitric Oxide Synthase Modulates Cyclooxygenase-2 Activity in the Heart of Conscious Rabbits During the Late Phase of Ischemic Preconditioning Circ. Res., March 22, 2002; 90(5): 602 - 608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhang and C. W. Leffler Compensatory role of NO in cerebral circulation of piglets chronically treated with indomethacin Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2002; 282(2): R400 - R410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Huang, Y. Wu, D. Sun, A. Koller, and G. Kaley Effect of estrogen on flow-induced dilation in NO deficiency: role of prostaglandins and EDHF J Appl Physiol, December 1, 2001; 91(6): 2561 - 2566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Nanji, K. Jokelainen, G. K. K. Lau, A. Rahemtulla, G. L. Tipoe, R. Polavarapu, and E.-N. Lalani Arginine Reverses Ethanol-Induced Inflammatory and Fibrotic Changes in Liver Despite Continued Ethanol Administration J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 832 - 839. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-H. Su, H.-i. Chen, and C. J. Jen C57BL/6 and BALB/c Bronchoalveolar Macrophages Respond Differently to Exercise J. Immunol., November 1, 2001; 167(9): 5084 - 5091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Devaux, C. Seguin, S. Grosjean, N. de Talance, V. Camaeti, A. Burlet, F. Zannad, C. Meistelman, P.-M. Mertes, and D. Longrois Lipopolysaccharide-Induced Increase of Prostaglandin E2 Is Mediated by Inducible Nitric Oxide Synthase Activation of the Constitutive Cyclooxygenase and Induction of Membrane-Associated Prostaglandin E Synthase J. Immunol., October 1, 2001; 167(7): 3962 - 3971. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Devaux, C. Seguin, S. Grosjean, N. de Talance, M. Schwartz, A. Burlet, F. Zannad, C. Meistelman, P.-M. Mertes, and D. Ungureanu-Longrois Retinoic Acid and Lipopolysaccharide Act Synergistically to Increase Prostanoid Concentrations in Rats In Vivo J. Nutr., October 1, 2001; 131(10): 2628 - 2635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Anstead, B. Chandrasekar, W. Zhao, J. Yang, L. E. Perez, and P. C. Melby Malnutrition Alters the Innate Immune Response and Increases Early Visceralization following Leishmania donovani Infection Infect. Immun., August 1, 2001; 69(8): 4709 - 4718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ueno, M. Murakami, T. Tanioka, K. Fujimori, T. Tanabe, Y. Urade, and I. Kudo Coupling between Cyclooxygenase, Terminal Prostanoid Synthase, and Phospholipase A2 J. Biol. Chem., September 7, 2001; 276(37): 34918 - 34927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Shinmura, Y.-T. Xuan, X.-L. Tang, E. Kodani, H. Han, Y. Zhu, and R. Bolli Inducible Nitric Oxide Synthase Modulates Cyclooxygenase-2 Activity in the Heart of Conscious Rabbits During the Late Phase of Ischemic Preconditioning Circ. Res., March 22, 2002; 90(5): 602 - 608. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
